Duopharma posts net profit of RM15.7mil in 4Q21

Duopharma Biotech group managing director Leonard Ariff Abdul Shatar

KUALA LUMPUR: Duopharma Biotech Bhd’s net profit fell almost 3% to RM15.71mil in the fourth quarter ended Dec 31, 2021 (4Q21) against RM16.19mil a year ago.

Revenue, however, rose 8.5% to RM145.44mil compared with RM134.08mil achieved a year prior.